First-trimester maternal plasma cell-free fetal DNA and preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 5, 2009, Pages 472.e1-472.e7

  Sifakis, Stavros ^a,b   Zaravinos, Apostolos ^b   Maiz, Nerea ^a   Spandidos, Demetrios A ^b   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

cell free fetal DNA; Doppler; preeclampsia; screening; uterine artery

Indexed keywords

DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CELL FREE SYSTEM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; DYS14 GENE; FETUS; FIRST TRIMESTER PREGNANCY; GENE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GESTATIONAL AGE; HUMAN; HUMAN GENOME; MALE; MATERNAL PLASMA; PREECLAMPSIA; PRIORITY JOURNAL; PULSE WAVE; UTERINE ARTERY;

ADULT; CASE-CONTROL STUDIES; DNA; FEMALE; FETUS; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PULSATILE FLOW; UTERINE ARTERY;

EID: 70350573382     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.05.025     Document Type: Article

References (39)

1. World Health Organization. Make every mother and child count: World Health Report, 2005 (2005), World Health Organization, Geneva
2. In: Lewis G. (Ed). Why mothers die 2000-2002: the sixth report of confidential enquiries into maternal deaths in the United Kingdom (2004), RCOG Press, London
3. American College of Obstetricians and Gynecologists: Committee on Practice Bulletins-Obstetrics. Diagnosis and management of preeclampsia and eclampsia: ACOG practice bulletin no: 33. Obstet Gynecol 99 (2002) 159-167
4. Brosens I., Robertson W.B., and Dixon H.G. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 93 (1967) 569-579
5. Khong T.Y., De Wolf F., Robertson W.B., and Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. BJOG 93 (1986) 1049-1059
6. Pijnenborg R., Anthony J., Davey D.A., et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. BJOG 98 (1991) 648-655
7. Plascencia W., Maiz N., Bonino S., Kaihura C., and Nicolaides K.H. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30 (2007) 742-749
8. Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 (2005) 565-572
9. Lo Y.M., Leung T.N., Tein M.S., et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45 (1999) 184-188
10. Zhong X.Y., Laivuori H., Livingston J.C., et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 184 (2001) 414-419
11. Smid M., Vassallo A., Lagona F., et al. Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann N Y Acad Sci 945 (2001) 132-137
12. Swinkels D.W., de Kok J.B., Hendriks J.C., Wiegerinck E., Zusterzeel P.L., and Steegers E.A. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 48 (2002) 650-653
13. Lau T.W., Leung T.N., Chan L.Y., et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 48 (2002) 2141-2146
14. Sekizawa A., Jimbo M., Saito H., et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 188 (2003) 480-484
15. Shimada K., Murakami K., Shozu M., Segawa T., Sumitani H., and Inoue M. Sex-determining region Y levels in maternal plasma: evaluation in abnormal pregnancy. J Obstet Gynaecol Res 30 (2004) 148-154
16. Farina A., Sekizawa A., Rizzo N., et al. Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. Prenat Diagn 24 (2004) 293-297
17. Zhong X.Y., Gebhardt S., Hillermann R., Tofa K.C., Holzgreve W., and Hahn S. Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia. Clin Chem 51 (2005) 1730-1733
18. Smid M., Galbiati S., Lojacono A., et al. Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies. Prenat Diagn 26 (2006) 785-790
19. Leung T.N., Zhang J., Lau T.K., and Lo Y.M. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 47 (2001) 137-139
20. Zhong X.Y., Holzgreve W., and Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 21 (2002) 77-83
21. Levine R.J., Qian C., Leshane E.S., et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 190 (2004) 707-713
22. Farina A., Sekizawa A., Sugito Y., et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia: a preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 24 (2004) 83-86
23. Crowley A., Martin C., Fitzpatrick P., et al. Free fetal DNA is not increased before 22 weeks in intrauterine growth restriction or pre-eclampsia. Prenat Diagn 27 (2007) 174-179
24. Snijders R.J., Noble P., Sebire N., Souka A., and Nicolaides K.H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation: Fetal Medicine Foundation First Trimester Screening Group. Lancet 352 (1998) 343-346
25. Kagan K.O., Wright D., Baker A., Sahota D., and Nicolaides K.H. Screening for trisomy 21 by maternal age, fetal NT, free β hCG and PAPP-A. Ultrasound Obstet Gynecol 31 (2008) 618-624
26. Davey D.A., and MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158 (1988) 892-898
27. Sherrill C.B., Marshall D.J., Moser M.J., et al. Nucleic acid analysis using an expanded genetic alphabet to quench fluorescence. J Am Chem Soc 126 (2004) 4550-4556
28. Johnson S.C., Sherrill C.B., Marshall D.J., Moser M.J., and Prudent J.R. A third base pair for the polymerase chain reaction: inserting isoC and isoG. Nucleic Acids Res 32 (2004) 1937-1941
29. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
30. von Dadelszen P., Magee L.A., and Roberts J.M. Subclassification of pre-eclampsia. Hypertens Pregnancy 22 (2003) 143-148
31. Witlin G.A., Saade G.R., Mattar F.M., and Sibai B.M. Predictors of neonatal outcome in women with severe pre-eclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol 1 suppl (1999) S19
32. Irgens H.U., Reisaeter L., Irgens L.M., and Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323 (2001) 1213-1217
33. Zimmermann B., El-Sheikhah A., Nicolaides K., Holzgreve W., and Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 51 (2005) 1598-1604
34. Picchiassi E., Coata G., Fanetti A., Centra M., Pennacchi L., and Di Renzo G.C. The best approach for early prediction of fetal gender by using free fetal DNA from maternal plasma. Prenat Diagn 28 (2008) 525-530
35. Holzgreve W., Ghezzi F., Di Naro E., Ganshirt D., Maymon E., and Hahn S. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 91 (1998) 669-672
36. Knight M., Redman C.W., Linton E.A., and Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. BJOG 105 (1998) 632-640
37. Al-Mufti R., Hambley H., Albaiges G., Lees C., and Nicolaides K.H. Increased fetal erythroblasts in women who subsequently develop pre-eclampsia. Hum Reprod 15 (2000) 1624-1628
38. Holzgreve W., Li J.C., Steinborn A., et al. Elevation in erythroblast count in maternal blood before the onset of preeclampsia. Am J Obstet Gynecol 184 (2001) 165-168
39. Akolekar R., Zaragoza E., Poon L.C.Y., Pepes S., and Nicolaides K.H. Maternal serum placental growth factor (PlGF) at 11 + 0 to 13 + 6 weeks of gestation in the prediction of preeclampsia. Ultrasound Obstet Gynecol 32 (2008) 732-739